A kidney stone analysis report identifies the chemical components of a stone that was passed or removed. This matters because stone composition gives clues about why stones formed and which prevention strategy is most useful. Calcium oxalate is the commonest component, but uric acid, calcium phosphate, infection-related struvite, cystine and drug-related stones require different evaluation. A stone report should be combined with urine tests, blood chemistry, diet/medical history and, in recurrent or high-risk stone formers, 24-hour urine testing. Composition alone does not explain every recurrence.

How stones should be analysed

Modern guidelines prefer reliable methods such as infrared spectroscopy or X-ray diffraction. Older wet-chemical methods are less accurate for mixed stones. The report may list several components with approximate percentages because many stones contain more than one mineral layer.

Calcium oxalate

Calcium oxalate monohydrate and/or dihydrate are very common. Prevention usually focuses on high fluid intake, normal dietary calcium, avoiding excessive sodium, moderating very high oxalate exposure and assessing urinary calcium, citrate, oxalate and volume when recurrent. A calcium stone does not automatically mean dietary calcium should be restricted; very low dietary calcium can increase oxalate absorption in some patients.

Calcium phosphate

Calcium phosphate stones may occur with higher urine pH, hypercalciuria and conditions such as distal renal tubular acidosis. Recurrent calcium-phosphate stones often justify metabolic evaluation because management can differ from pure calcium oxalate disease.

Uric acid

Uric acid stones form mainly in persistently acidic urine and are associated with metabolic syndrome, diabetes, obesity, gout and high purine load in some patients. Unlike most calcium stones, uric acid stones can sometimes be dissolved with medically supervised urinary alkalinisation if the diagnosis and anatomy are appropriate.

Struvite / infection stones

Struvite (magnesium ammonium phosphate) is associated with urease-producing urinary infection and often forms in alkaline urine. Treatment generally requires both infection control and complete or near-complete removal of stone burden because residual fragments can regrow. Culture and anatomical evaluation are important.

Cystine

Cystine stones suggest cystinuria, an inherited amino-acid transport disorder. They can recur aggressively and usually require specialist prevention with very high urine-volume targets, alkalinisation and sometimes specific medicines. Family counselling/testing may be relevant.

Why mixed composition matters

A stone labelled “80% calcium oxalate, 20% calcium phosphate” still belongs broadly to calcium stone disease, but the phosphate component and urine pH can influence prevention. A recurrent stone that changes composition may signal a change in urine chemistry, infection, medication or metabolic state.

Who needs a full metabolic evaluation?

• Recurrent stone formers.
• Young patients, bilateral/multiple stones or strong family history.
• Cystine, uric acid, struvite or unusual/drug stones.
• Solitary kidney or high consequence of recurrence.
• Nephrocalcinosis, bowel disease/bariatric surgery or suspected metabolic disorder.

If the stone is not available for analysis

CT density, urine pH, X-ray visibility and clinical history can suggest composition, but they are imperfect substitutes. A radiolucent stone with low urine pH may be uric acid, for example, yet definitive preventive advice should avoid overconfidence without analysis. If another stone is passed in the future, collect it dry in a clean container and send it through a laboratory that uses a validated analytical method.

Getting the best value from a stone-analysis result

Whenever possible, send a freshly passed or surgically retrieved stone fragment for analysis rather than assuming composition from X-ray or CT. Keep the report because a future stone with a different composition can change the metabolic work-up. If the laboratory uses only a vague term such as “calcium stone” without a validated analytical method, a more precise analysis may be useful in recurrent high-risk disease.

Prevention should begin with adequate fluid intake for nearly all stone formers, but diet and medication are then individualised. A 24-hour urine can reveal low volume, hypercalciuria, hypocitraturia, hyperoxaluria, low pH or other abnormalities that cannot be inferred reliably from the stone composition alone.

How stone composition changes prevention

A stone-analysis report is most valuable when it changes the prevention plan. Calcium oxalate should not automatically lead to dietary calcium restriction; normal dietary calcium with meals can actually reduce intestinal oxalate absorption. Uric acid stones raise questions about urine pH and metabolic syndrome and may be amenable to dissolution in selected patients. Cystine stones trigger lifelong high-risk evaluation, while struvite suggests infection with urease-producing organisms and a need to think about complete stone clearance.

Mixed stones are common. The dominant and clinically important components should be interpreted with a 24-hour urine profile, serum chemistry, diet, medications and recurrence history rather than prescribing one universal ‘stone diet’.

Who should go beyond stone analysis to a metabolic work-up

Recurrent stone formers, bilateral or multiple stones, young-onset disease, solitary kidney, cystine/uric-acid/infection stones, nephrocalcinosis, bowel disease or strong family history are among the situations where a more complete metabolic evaluation is particularly useful. This may include serum chemistry and one or more properly collected 24-hour urine samples.

A single stone fragment also has sampling limitations. Different layers of the same stone can contain different minerals, and analysis methods differ in quality. Infrared spectroscopy or X-ray diffraction is more informative than older purely chemical tests when available.

What to bring for consultation

• Stone analysis report and, if possible, the actual remaining sample.
• CT/ultrasound showing total stone burden.
• Serum creatinine, calcium, uric acid and other chemistry if done.
• Urine pH and 24-hour urine results when available.
• Diet, fluid, medicines/supplements and prior stone-procedure history.

FAQs

Related reading

• CT KUB Report Explained
• Urine Routine Microscopy Report Explained
• Serum Creatinine Test Explained
• Urologist in Latur
• Kidney Stone Treatment in Latur

References

• European Association of Urology. EAU Guidelines on Urolithiasis. 2026 https://uroweb.org/guidelines/urolithiasis